The pathophysiology of Alzheimer's disease (AD) involves the deposition of amyloid in the brain and the extensive loss of neurons. The mechanisms subserving neuronal death in the disease remain unclear, although it has been postulated that this is due to apoptosis. There is compelling evidence that inflammatory processes play a role in disease progression and pathology. Amyloid plaque deposition is accompanied by the association of microglia with the senile plaque, and this interaction stimulates these cells to undergo phenotypic activation and the subsequent elaboration of proinflammatory and neurotoxic products. This review focuses on the mechanisms by which neurons are lost in AD and the role microglial proinflammatory products play in neuronal death.
Ahlijanian MK
, Barrezueta NX, Williams RD, Jakowski A, Kowsz KP, McCarthy S, and others. 2000. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci U S A97:2910–2915.
2.
Aisen PS
, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, and others. 2000. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology54:588–593.
3.
Akiyama H
, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, and others. 2000. Inflammation and Alzheimer's disease. Neurobiol Aging21:383–421.
4.
Bales KR
, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, and others. 1999. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A96:15233–15238.
5.
Bamberger ME
, Landreth GE. 2001. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease. Microsc Res Tech54:59–70.
6.
Bard F
, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, and others. 2000. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med6:916–919.
7.
Bianca VD
, Dusi S, Bianchini E, Dal Pra I, Rossi F. 1999. beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem274:15493–15499.
8.
Bradt BM
, Kolb WP, Cooper NR. 1998. Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J Exp Med188:431–438.
9.
Breitner JC
. 1996. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med47:401–411.
10.
Chung H
, Brazil MI, Soe TT, Maxfield FR. 1999. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J Biol Chem274:32301–32308.
11.
Combs CK
, Johnson DE, Karlo JC, Cannady SB, Landreth GE. 2000. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci20:558–567.
12.
Combs CK
, Karlo JC, Kao SC, Landreth GE. 2001. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci21:1179–1188.
13.
Cotman CW
, Su JH. 1996. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol6:493–506.
14.
De Strooper B
, Annaert W. 2001. Where Notch and Wnt signaling meet. The presenilin hub. J Cell Biol152:F17–F20.
15.
Emmerling MR
, Watson MD, Raby CA, Spiegel K. 2000. The role of complement in Alzheimer's disease pathology. Biochim Biophys Acta1502:158–171.
16.
Estus S
, Tucker HM, van Rooyen C, Wright S, Brigham EF, Wogulis M, and others. 1997. Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant “apoptotic” pattern of gene induction. J Neurosci17:7736–7745.
17.
Frenkel D
, Kariv N, Solomon B. 2001. Generation of auto-antibodies towards Alzheimer's disease vaccination. Vaccine19:2615–2619.
18.
Giovanni A
, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, and others. 2000. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J Biol Chem275:11553–11560.
19.
Giovanni A
, Wirtz-Brugger F, Keramaris E, Slack R, Park DS. 1999. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J Biol Chem274:19011–19016.
20.
Giulian D
, Corpuz M, Chapman S, Mansouri M, Robertson C. 1993. Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the nervous system. J Neurosci Res36:681–693.
21.
Haga S
, Ikeda K, Sato M, Ishii T. 1993. Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res601:88–94.
22.
Harris CA
, Johnson EM Jr. 2001. BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J Biol Chem8:8-8.
23.
Heneka MT
, Feinstein DL, Galea E, Gleichmann M, Wullner U, Klockgether T. 1999. Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokineinduced apoptotic cell death by inhibition of inducible nitric oxide synthase. J Neuroimmunol100:156–168.
24.
Heneka MT
, Loschmann PA, Gleichmann M, Weller M, Schulz JB, Wullner U, and others. 1998. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J Neurochem71:88–94.
25.
Imaizumi K
, Morihara T, Mori Y, Katayama T, Tsuda M, Furuyama T, and others. 1999. The cell death-promoting gene DP5, which inter-acts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein. J Biol Chem274:7975–7981.
26.
Ishii K
, Muelhauser F, Liebl U, Picard M, Kuhl S, Penke B, and others. 2000. Subacute NO generation induced by Alzheimer's beta-amyloid in the living brain: reversal by inhibition of the inducible NO synthase. FASEB J14:1485–1489.
27.
Ivins KJ
, Thornton PL, Rohn TT, Cotman CW. 1999. Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Neurobiol Dis6:440–449.
28.
Janus C
, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, and others. 2000. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature408:979–982.
29.
Jiang H
, Burdick D, Glabe CG, Cotman CW, Tenner AJ. 1994. beta-amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol152:5050–5059.
Kesavapany S
, Lau KF, McLoughlin DM, Brownlees J, Ackerley S, Leigh PN, and others. 2001. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. Eur J Neurosci13:241–247.
32.
Lee MS
, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. 2000. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature405:360–364.
33.
Lucas JJ
, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J. 2001. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J20:27–39.
34.
Mackenzie IR
. 2000. Anti-inflammatory drugs and Alzheimer-type pathology in aging. Neurology54:732–734.
35.
Mackenzie IR
, Munoz DG. 1998. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology50:986–990.
McDonald DR
, Brunden KR, Landreth GE. 1997. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J Neurosci17:2284–2294.
38.
Meda L
, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, and others. 1995a. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature374:647–650.
39.
Meda L
, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, and others. 1995b. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature374:647–650.
40.
Morgan D
, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, and others. 2000. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature408:982–985.
41.
Nagy Z
.2000. Cell cycle regulatory failure in neurones: causes and consequences. Neurobiol Aging21:761–769.
42.
Ogura T
, Tatemichi M, Esumi H. 1997. TNF-alpha mediates inducible nitric oxide synthase expression in human neuroblastoma cell line by cisplatin. Biochem Biophys Res Commun233:788–791.
43.
Patrick GN
, Zhou P, Kwon YT, Howley PM, Tsai LH. 1998. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem273:24057–24064.
44.
Rich JB
, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J. 1995. Nonsteroidal anti-inflammatory drugs in Alzheimer's dis-ease. Neurology45:51–55.
45.
Rohn TT
, Head E, Su JH, Anderson AJ, Bahr BA, Cotman CW, and others. 2001. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am J Pathol158:189–198.
46.
Sainati S
, Ingram D, Talwalker G, Geis G. 2000. Results of a double-blind, randomized, placebo-controlled study of celecoxib in the treatment of Alzheimer's disease. Sixth International Stockholm/ Springfield Symposium on Advances in Alzheimer Therapy. Stockholm, Sweden, April, p. 180-180.
47.
Schenk D
, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, and others. 1999. Immunization with amyloid-beta attenuates Alzheimerdisease-like pathology in the PDAPP mouse. Nature400:173–177.
48.
Shimohama S
. 2000. Apoptosis in Alzheimer's disease—an update. Apoptosis5:9–16.
49.
Smith MA
, Richey Harris PL, Sayre LM, Beckman JS, Perry G. 1997. Widespread peroxynitrite-mediated damage in Alzheimer's dis-ease. J Neurosci17:2653–2657.
50.
Soriano S
, Kang DE, Fu M, Pestell R, Chevallier N, Zheng H, and others. 2001. Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J Cell Biol152:785–794.
51.
Stewart WF
, Kawas C, Corrada M, Metter EJ. 1997. Risk of Alzheimer's disease and duration of NSAID use. Neurology48:626–632.
52.
Troy CM
, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, Shelanski ML. 2000. Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci20:1386–1392.
53.
Troy CM
, Rabacchi SA, Xu Z, Maroney AC, Connors TJ, Shelanski ML, and others. 2001. beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J Neurochem77:157–164.
54.
Venters HD
, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW. 1999. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci U S A96:9879–9884.
55.
Webster SD
, Galvan MD, Ferran E, Garzon-Rodriguez W, Glabe CG, Tenner AJ. 2001. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q. J Immunol166:7496–7503.
56.
Weldon DT
, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O'Hare E, and others. 1998. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci18:2161–2173.
57.
Wu Q
, Combs C, Cannady SB, Geldmacher DS, Herrup K. 2000. Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons. Neurobiol Aging21:797–806.
58.
Yang Y
, Geldmacher DS, Herrup K. 2001. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci21:2661–2668.
59.
Yuan J
, Yankner BA. 2000. Apoptosis in the nervous system. Nature407:802–809.
